GlobeNewswire by notified

AKVA group ASA: Q3 2023 financial reporting

Share

Acceptable activity level and profitability in Sea Based but challenging post smolt market in Norway

AKVA group delivered revenue for Q3 of MNOK 817 (840), a decrease of 3% compared to Q3 2022.

EBITDA increased from MNOK 25 in Q3 2022 to MNOK 78 in Q3 2023.

Order intake of MNOK 600 (650) in Q3 and order backlog of BNOK 2,6 at the end of September 2023.

Acquisition of 51% of the shares in Submerged AS was completed in Q3 with the option to increase the ownership to 100% in 2028 based on certain conditions

Ownership in Newfoundland Aqua Service Ltd was increased from 70% to 98,5% in October through execution of option

A rightsizing process, targeting MNOK 45 in annual cost savings, will be carried out in Q4 to adapt the organization to the current and expected activity level

Due to change in market conditions AKVA will revise the medium-term financial targets during Q4

The activity in the first three quarters of 2023 were somewhat higher compared to last year. Overall, the order intake was sound with the award of RAS contract for Nordic Aqua Partners (MEUR 40) and the post smolt contract for Cermaq Norway (minimum MEUR 60) as the largest contracts. However, the introduction of the resource tax has a negative impact on the activity level both in Land Based and parts of the Sea Based business, and the market outlook is challenging and uncertain. Profitability is continuing to improve compared to last year but is still below expectations. The Land Based business segment is still impacted by a high cost base compared to current activity level and by lower profitability in parts of the project portfolio. The profitability in the Sea Based business segment is acceptable with a healthy product mix supported by the commercial breakthrough of deep farming concepts.

Due to change in market conditions a rightsizing process, targeting MNOK 45 in annual cost savings, will be executed during Q4 to adapt the organization to the current and expected activity level.

Sea Based Technology (SBT)
SBT revenue for Q3 2023 ended at MNOK 660 (681). EBITDA and EBIT for the segment in Q3 ended at MNOK 79 (79) and MNOK 41 (44), respectively. The related EBITDA and EBIT margins were 11.9% (11.5%) and 6.3% (6.4%), respectively.

Order intake in Q3 2023 was MNOK 574 compared to MNOK 450 in Q3 2022. Order backlog ended at MNOK 731 compared to MNOK 672 last year.

The Nordic region experienced an increase in revenue from MNOK 417 in Q3 2022 to MNOK 381 in Q3 2023.

In the Americas region, the revenue was MNOK 171, which is a decrease from 186 MNOK in the third quarter last year.

Europe and Middle East (EME) had a revenue of MNOK 73 in Q3 2023, compared to the revenue of MNOK 114 in the third quarter last year.

Land Based Technology (LBT)
Revenues for the third quarter were MNOK 124 (134). EBITDA and EBIT ended at MNOK -11 (-63) and MNOK -13 (-106), respectively. The related EBITDA and EBIT margins were -8.5% (-46.6%) and -10.4% (-78.9%). EBITDA and EBIT in Q3 2022 was significantly impacted by cost accruals for restructuring and cost saving programs.

Order intake in Q3 2023 of MNOK 4 compared to MNOK 167 in Q3 2022. Order backlog ended at MNOK 1,728, compared to MNOK 812 last year.

Digital (DI)
The revenue in the segment was MNOK 33 (25) in Q3 2023. EBITDA and EBIT ended at MNOK 10 (9) and MNOK 0 (3), respectively. The related EBITDA and EBIT margins were 29.9% (38.0%) and 0.8% (11.5%). The order intake was MNOK 21 (32) in the quarter.

Balance sheet
Working capital as a percentage of 12 months rolling revenue is 8.6% (5.9%). Cash and unused credit facilities amounted to MNOK 526 (793) at the end of Q3. Total assets and total equity amounted to MNOK 3,732 and MNOK 1,176 respectively, resulting in an equity ratio of 31.8% (34.0%) at the end of Q3 2023.

Dividend
The Company’s main objective is to maximize the return on the investment made by its shareholders through both increased share prices and dividend payments. The company has decided not to pay any dividend in 2023.

Order Backlog
The order backlog at the end of Q2 was MNOK 2,609 (1,579). MNOK 1,728 or 66% of total order backlog at the end of Q3 relates to Land Based Technology (LBT).

Outlook
Salmon prices expected to remain strong driven by reduced supply

The implications from the introduction of new resource tax in Norway are negative both for Land Based business and parts of Sea Based business

Measures will be taken in Q4 23 to adopt the cost base to the current and expected activity level

Due to change in market conditions AKVA will revise the medium-term financial targets during Q4

About AKVA group
AKVA group is a technology and service partner to the aquaculture industry worldwide. The company has 1 410 employees, offices in 11 countries and had a total turnover of NOK 3.4 billion in 2022. We are a public listed company operating in one of the world’s fastest growing industries and supply everything from single components to complete installations, both for sea farming and land based aquaculture. AKVA group is recognized as a pioneer and technology leader through more than 40 years.

Dated: 10 November 2023
AKVA group ASA

Web: www.akvagroup.com

CONTACTS:

Knut Nesse Chief Executive Officer
Phone:+47 51 77 85 00
Mobile:+47 91 37 62 20
E-mail:knesse@akvagroup.com


Rony MeinkøhnChief Financial Officer
Phone:+47 51 77 85 00
Mobile:+47 98 20 67 76
E-mail:rmeinkohn@akvagroup.com


This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Zymeworks Announces Participation in Upcoming Investor Conferences27.2.2024 12:00:00 CET | Press release

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: TD Cowen 44th Annual Health Care Conference: Zymeworks’ management will participate in one-on-one meetings and present on March 6th at 11:10 am Eastern Time (ET) in Boston, MA.Barclays 26th Annual Global Healthcare Conference: Zymeworks’ management will participate in one-on-one meetings and a fireside chat on March 14th at 11:45 am ET in Miami, FL. All presentations and webcasts will be available on Zymeworks’ website at http://ir.zymeworks.com/events-and-presentations. About Zymeworks Inc. Zymeworks is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional bio

Philips launches new Azurion neuro biplane system at #ECR2024 to speed up and improve minimally invasive diagnosis and treatment of neurovascular patients27.2.2024 12:00:00 CET | Press release

February 27, 2024 New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system. Designed to streamline neurovascular procedures and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips is partnering with its customers to improve productivity and access to more sustainable healthcare. Minimally invasive procedures enabled by interventional systems like Azurion are a key part of

Millicom (Tigo) Q4 2023 Earnings Release27.2.2024 12:00:00 CET | Press release

Millicom (Tigo) Q4 2023 Earnings Release Luxembourg, February 27, 2024 –Millicom is pleased to announce its fourth quarter 2023 results. Please find below links to the Q4 2023 Earnings Release and IAS 34 Interim Condensed Consolidated Financial Statements. Highlights* Revenue grew 6.8% driven by Service revenue up 7.7%, reflecting the effect of stronger currencies and organic growth of 3.2%, up from 1.8% in Q3 thanks mostly to large B2B contracts in Panama, as well as faster growth in Colombia and Bolivia. Operating profit declined 3.8%, while EBITDA grew 1.6%, and both were impacted by $42 million of one-off severance costs in the quarter. Excluding severance and the benefit of stronger currencies, EBITDA grew 5.3% organically, with Colombia up 24.5%, as margins continued to expand in the country.Operating cash flow was $294 million in Q4 and $1.3 billion for the full year, up 12.3% organically excluding severance and other one-offs thanks largely to improved performance in our Colomb

Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 29 June 202327.2.2024 11:59:13 CET | Press release

To Nasdaq Copenhagen A/S 27 February 2024 Announcement no 20/2024 Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 29 June 2023 Jyske Realkredit hereby publish Supplement no. 1 to Base prospectus dated 29 June 2023 for covered bonds, mortgage bonds and bonds issued pursuant to Section 15 of the Danish Mortage-Credit Loans and Mortgage-Credit Bonds etc. Act. Jyske Realkredit’s Base Prospectus dated 29 June 2023 and Supplements are available for download in Danish and English on Jyske Realkredit’s website www.jyskerealkredit.dk. In the event of discrepancies between the original Danish text and the English translation, the Danish text shall prevail. Jyske Realkredit’s Supplement no 1 is also enclosed this announcement. For more information, please contact: Head of Rating and IR, Christian Bech-Ravn on telephone (+45) 89 89 92 25Legal Counsel Berit Fredberg on telephone (+45) 89 89 79 64 Yours sincerely Jyske Realkredit Søren Winkler Senior Director Attachment 20240

Jyske Realkredit offentliggør tillæg nr. 1 til Basisprospekt27.2.2024 11:59:13 CET | pressemeddelelse

Til Nasdaq Copenhagen A/S 27. februar 2024 Meddelelse nr. 20/2024 Jyske Realkredit offentliggør tillæg nr. 1 til Basisprospekt Jyske Realkredit offentliggør hermed tillæg nr. 1 til Basisprospekt af 29. juni 2023 for Særligt Dækkede Obligationer, Realkreditobligationer og obligationer i medfør af § 15 i lov om realkreditlån og realkreditobligationer (§ 15 obligationer). Jyske Realkredits Basisprospekt af 29. juni 2023 og tillæg er tilgængelige i elektronisk form på dansk og engelsk på Jyske Realkredits hjemmeside www.jyskerealkredit.dk. Ved uoverensstemmelse mellem den danske og den engelske udgave er den danske udgave gældende. Tillæg nr. 1 er desuden vedhæftet denne meddelelse. Spørgsmål vedrørende denne meddelelse kan rettes til: Head of Rating and IR, Christian Bech-Ravn på telefon 89 89 92 25Jurist Berit Fredberg på telefon 89 89 79 64 Venlig hilsen Jyske Realkredit Søren Winkler Områdedirektør Vedhæftet fil 20240227 Tillæg 1 til basisprospekt af 29 juni 2023

HiddenA line styled icon from Orion Icon Library.Eye